Literature DB >> 32730413

Characterization of kidney complications in patients with sickle cell anemia.

M C Isaza-López1, L F Rojas-Rosas1, L Echavarría-Ospina2, L M Serna-Higuita3.   

Abstract

INTRODUCTION: Sickle cell nephropathy (SCN) is a poorly studied complication of pediatric patients. It appears in different forms, including glomerulopathy, and tubulopathies.
OBJECTIVE: To describe acute and chronic renal complications in patients with sickle cell anemia (SCA). PATIENTS AND
METHOD: Re trospective study. Pediatric patients with confirmed diagnosis of sickle cell disease were included who had a nephro-urology study. Hemoglobin electrophoresis pattern, presence and type of renal involvement, and presence of cardiac involvement were recorded. Bivariate analysis was perfor med to compare patients with and without SCN.
RESULTS: 79 patients were included, 59.5% of them were men, and the most frequent electrophoresis pattern was Hb-SS (60.9%). The SCN oc curred in 70% of patients with an average age of 114 months (RIQ 65-157). The most frequently observed alterations were glomerular hyperfiltration, microalbuminuria, acute kidney injury, ar terial hypertension, and hyposthenuria. In the bivariate analysis, an abnormal echocardiogram result was presented more frequently in patients with SCN (84.8% vs. 54.3% p = 0.01), as well as more frequent use of nephrotoxic drugs (74.5% vs. 54.2% p = 0.07).
CONCLUSIONS: Our findings suggest that sickle cell nephropathy may occur at an early age, where glomerular hyperfiltration is very common. Cardiopulmonary complications in patients with SCA may be related to the presence of SCN.

Entities:  

Mesh:

Year:  2020        PMID: 32730413     DOI: 10.32641/rchped.v91i1.1274

Source DB:  PubMed          Journal:  Rev Chil Pediatr        ISSN: 0370-4106


  1 in total

1.  Renal Abnormalities among Sickle Cell Disease Patients in a Poor Management Setting: A Survey in the Democratic Republic of the Congo.

Authors:  Paul Kambale-Kombi; Roland Marini Djang'eing'a; Jean-Pierre Alworong'a Opara; Jean-Paulin Mbo Mukonkole; Vincent Bours; Serge Tonen-Wolyec; Dieu-Merci Mbumba Lupaka; Lucien Bolukaoto Bome; Charles Kayembe Tshilumba; Salomon Batina-Agasa
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-07-01       Impact factor: 3.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.